Silva-Batista, Carla
Wilhelm, Jennifer L.
Scanlan, Kathleen T.
Stojak, Margaret
Carlson-Kuhta, Patricia
Chen, Siting
Liu, William
de la Huerta, Tomas Nicolás García
Horak, Fay B.
Mancini, Martina
King, Laurie A.
Funding for this research was provided by:
National Institutes of Health (R01HD107074, R01HD107074, R01HD107074)
Article History
Received: 16 September 2023
Accepted: 26 September 2023
First Online: 13 October 2023
Declarations
:
: The study was approved by the Institutional Review Board at Oregon Health & Science University (OHSU) (eIRB #24453). The trial has been prospectively registered at the Clinical Trials Registry (NCT05680597). Each participant will sign the informed consent form before inclusion in the study.
: As the study includes images of the participants, we ensure a consent for publication was obtained from the participants.
: CSB, JLW, KTS, MS, PCK, SC, WL, TGDLH, MM, and LAK declare that they have no conflicts of interest relevant to the content of this manuscript. OHSU and FBH have significant financial interest in APDM, a Clario company, that may have a commercial interest in the results of this research and technology. This potential conflict has been reviewed and managed by OHSU.